Racial Variations in 

Prostate Cancer Incidence

Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health Professionals Elizabeth A. Platz, Eric B. Rimm, Walter C. Willett, Philip W. Kantoff, Edward Giovannucci

Affiliations of authors: E. A. Platz, Department of Nutrition, Harvard School of Public Health, Boston, MA; E. B. Rimm, W. C. Willett, E. Giovannucci, Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, and the Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston; P. W. Kantoff, Lank Center for Genitourinary Oncology, Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School.

Correspondence to present address: Elizabeth A. Platz, Sc.D., M.P.H., Department of Epidemiology, The Johns Hopkins School of Hygiene and Public Health, 615 N. Wolfe St., Baltimore, MD 21205 (e-mail: eplatz@jhsph.edu).

Background: Racial variation in prostate cancer incidence in the United States is pronounced, with African-American men having the highest rates. Whether differences in the distribution of known or suspected risk factors among racial groups explain this variation is unknown.

Methods: We evaluated prospectively the relation between prostate cancer and race among 45 410 U.S. male health professionals aged 4075 years in 1986. We used multivariable, pooled logistic regression to adjust the rate ratio (RR) for potential dietary and lifestyle risk factors. We also measured circulating levels of steroid hormones, sex hormone-binding globulin, and vitamin D metabolites and length of the androgen receptor gene CAG repeat in a sample of African-American (n = 43), Asian (n = 52), and white (n = 55) participants and assessed variation by race in these possible prostate epithelial cell growth mediators by use of analysis of variance. Statistical tests were two-sided.

Results: The age-adjusted RR for prostate cancer was 1.73 (95% confidence interval [CI] = 1.232.45) for African-American men compared with white men. After multivariate adjustment, the RR increased to 1.81 (95% CI = 1.272.58). The rate of prostate cancer did not differ between Asians and whites. Steroid hormone and 1,25-dihydroxyvitamin D levels did not vary appreciably by race. However, the mean number of androgen receptor gene CAG repeats was lower among African-Americans (mean standard deviation = 20.1 3.5) than among whites (22.1 3.1; P = .007) and Asians (22.1 3.9; P = .009).

Conclusions: Our results confirm the elevated incidence of prostate cancer among African Americans and show that it is not explained by differences in the distribution of possible dietary and lifestyle risk factors in this cohort. Racial variation in length of the androgen receptor gene CAG repeat may explain a small part of the excess risk of prostate cancer among African-American men in this cohort.

December 2000 study, JNCI

Report on Metastatic Prostate Cancer

JNCI February 2001

DNA structure characteristic of metastasis: Press Release
Race/Ethnicity & Watchful Waiting:Prostate Ca

J Gen Internal Med, 2/04

Race/Literacy Effects on Prostate Ca Biology & Access

Abstract #6019 ASCO, 2004

Race & Prostate Ca:Attitudes on Diagnosis/Treatment
Racial Disparity of Epidermal Growth Factor Receptor
Two Books for Black Men on Prostate Cancer

Hilton Publishing, posted 9/06 Prostate Awareness Month

Cultural Disparities in Diagnosis &Treatment of Prostate Ca

J Urol Nurs, 12/06

References: Cultural Differences Prostate Ca

Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.